APA

Lara P. N., Gandara D. R., Longmate J., Gumerlock P. H., Lau D. H., Edelman M. J., Gandour-Edwards R., Mack P. C., Israel V., Raschko J., Frankel P., Perez E. A., Lenz H. J. & Doroshow J. H. (20010830). Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. : Cancer chemotherapy and pharmacology.

Chicago

Lara P N, Gandara D R, Longmate J, Gumerlock P H, Lau D H, Edelman M J, Gandour-Edwards R, Mack P C, Israel V, Raschko J, Frankel P, Perez E A, Lenz H J and Doroshow J H. 20010830. Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. : Cancer chemotherapy and pharmacology.

Harvard

Lara P. N., Gandara D. R., Longmate J., Gumerlock P. H., Lau D. H., Edelman M. J., Gandour-Edwards R., Mack P. C., Israel V., Raschko J., Frankel P., Perez E. A., Lenz H. J. and Doroshow J. H. (20010830). Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. : Cancer chemotherapy and pharmacology.

MLA

Lara P N, Gandara D R, Longmate J, Gumerlock P H, Lau D H, Edelman M J, Gandour-Edwards R, Mack P C, Israel V, Raschko J, Frankel P, Perez E A, Lenz H J and Doroshow J H. Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. : Cancer chemotherapy and pharmacology. 20010830.